Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Mr. Francesco BianchiIndependent Non-Executive Director | -1,80k | 136,35k | Verkauf | 75,75 | 7,23k | -19,94% |
| 2026-03-30 | Mr. Ahmet TezelChief Innovation Officer | -1,19k | 72,67k | Derivative Exercise and Sale | 61,27 | 4,16k | - |
| 2026-03-30 | Mr. Ahmet TezelChief Innovation Officer | 2,22k | 0,00 | Derivative Exercise and Retained Stock | - | 4,16k | 114,83% |
| 2026-03-30 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | -1,37k | 83,94k | Derivative Exercise and Sale | 61,27 | 10,97k | - |
| 2026-03-30 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | 1,81k | 0,00 | Derivative Exercise and Retained Stock | - | 10,97k | 19,80% |
| 2026-03-30 | Mr. Alex ShvartsburgCFO | -12,87k | 788,42k | Derivative Exercise and Sale | 61,27 | 44,65k | - |
| 2026-03-30 | Mr. Alex ShvartsburgCFO | 17,97k | 0,00 | Derivative Exercise and Retained Stock | - | 44,65k | 67,34% |
| 2026-03-30 | Mr. Vladimir A. MakatsariaCEO & Director | -11,16k | 683,71k | Derivative Exercise and Sale | 61,27 | 14,17k | - |
| 2026-03-30 | Mr. Vladimir A. MakatsariaCEO & Director | 9,88k | 0,00 | Derivative Exercise and Retained Stock | - | 14,17k | 230,70% |
| 2026-03-30 | Ms. Natalia KozminaChief HR Officer | -1,37k | 84,18k | Derivative Exercise and Sale | 61,27 | 5,02k | - |
| 2026-03-30 | Ms. Natalia KozminaChief HR Officer | 5,02k | 0,00 | Derivative Exercise and Retained Stock | - | 5,02k | - |
| 2026-03-30 | Ms. Stephanie BoltonPresident of Global Epilepsy | -8,38k | 513,26k | Derivative Exercise and Sale | 61,27 | 22,19k | - |
| 2026-03-30 | Ms. Stephanie BoltonPresident of Global Epilepsy | 9,44k | 0,00 | Derivative Exercise and Retained Stock | - | 22,19k | 74,02% |
| 2026-03-11 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | 91,00 | 5,24k | Derivative Exercise and Retained Stock | 57,60 | 9,16k | 1,00% |
| 2026-03-11 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | -2,05k | 9,55k | Derivative Exercise and Sale | 57,60 - 62,26 | 9,16k | - |
| 2025-12-15 | Mr. Michael D. HutchinsonInsider | 1,13k | 0,00 | Derivative Exercise and Retained Stock | - | 6,80k | 19,98% |
| 2025-12-15 | Mr. Michael D. HutchinsonInsider | -1,12k | 70,75k | Derivative Exercise and Sale | 63,06 | 6,80k | - |
| 2025-12-15 | Ms. Susan M. PodlogarIndependent Director | 2,09k | 0,00 | Derivative Exercise and Retained Stock | - | 2,09k | - |
| 2025-12-15 | Ms. Susan M. PodlogarIndependent Director | -269,00 | 16,96k | Derivative Exercise and Sale | 63,06 | 2,09k | - |
| 2025-12-15 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | 551,00 | 0,00 | Derivative Exercise and Retained Stock | - | 9,07k | 6,47% |
| 2025-12-15 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | -416,00 | 26,23k | Derivative Exercise and Sale | 63,06 | 9,07k | - |
| 2025-11-18 | Ms. Brooke Elizabeth StoryIndependent Director | -250,00 | 13,49k | Verkauf | 53,94 | 6,23k | -3,86% |
| 2025-09-15 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | 366,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,52k | 4,49% |
| 2025-09-15 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | -277,00 | 15,35k | Derivative Exercise and Sale | 55,43 | 8,52k | - |
| 2025-08-25 | Mr. Francesco BianchiIndependent Non-Executive Director | -1,50k | 84,75k | Verkauf | 56,50 | 9,03k | -14,25% |
| 2025-06-15 | Mr. James Christopher BarryIndependent Director | 3,01k | 0,00 | Derivative Exercise and Retained Stock | - | 4,36k | 221,68% |
| 2025-06-15 | Mr. James Christopher BarryIndependent Director | -410,00 | 18,76k | Derivative Exercise and Sale | 45,76 | 4,36k | - |
| 2025-06-15 | Mr. William A. KozyChairman of Board | 4,26k | 0,00 | Derivative Exercise and Retained Stock | - | 32,57k | 15,05% |
| 2025-06-15 | Mr. William A. KozyChairman of Board | -581,00 | 26,59k | Derivative Exercise and Sale | 45,76 | 32,57k | - |
| 2025-06-15 | Mr. Todd Charles SchermerhornIndependent Non-Executive Director | 3,01k | 0,00 | Derivative Exercise and Retained Stock | - | 9,06k | 49,63% |
| 2025-06-15 | Mr. Todd Charles SchermerhornIndependent Non-Executive Director | -410,00 | 18,76k | Derivative Exercise and Sale | 45,76 | 9,06k | - |
| 2025-06-15 | Mr. Francesco BianchiIndependent Non-Executive Director | 3,01k | 0,00 | Derivative Exercise and Retained Stock | - | 10,53k | 39,96% |
| 2025-06-15 | Mr. Francesco BianchiIndependent Non-Executive Director | -410,00 | 18,76k | Derivative Exercise and Sale | 45,76 | 10,53k | - |
| 2025-06-15 | Dr. Sharon O'KaneIndependent Non-Executive Director | 1,81k | 0,00 | Derivative Exercise and Retained Stock | - | 11,30k | 19,06% |
| 2025-06-15 | Dr. Sharon O'KaneIndependent Non-Executive Director | -1,61k | 73,49k | Derivative Exercise and Sale | 45,76 | 11,30k | - |
| 2025-06-15 | Mr. Ahmet TezelChief Innovation Officer | 1,94k | 0,00 | Derivative Exercise and Retained Stock | - | 1,94k | - |
| 2025-06-15 | Mr. Ahmet TezelChief Innovation Officer | -1,03k | 47,22k | Derivative Exercise and Sale | 45,76 | 1,94k | - |
| 2025-06-15 | Mr. Peter Marshall WilverIndependent Director | 3,01k | 0,00 | Derivative Exercise and Retained Stock | - | 6,74k | 80,55% |
| 2025-06-15 | Mr. Peter Marshall WilverIndependent Director | -410,00 | 18,76k | Derivative Exercise and Sale | 45,76 | 6,74k | - |
| 2025-06-15 | Ms. Stacy Enxing SengIndependent Non-Executive Director | 3,01k | 0,00 | Derivative Exercise and Retained Stock | - | 11,75k | 34,37% |
| 2025-06-15 | Ms. Stacy Enxing SengIndependent Non-Executive Director | -410,00 | 18,76k | Derivative Exercise and Sale | 45,76 | 11,75k | - |
| 2025-06-15 | Ms. Brooke Elizabeth StoryIndependent Director | 3,01k | 0,00 | Derivative Exercise and Retained Stock | - | 6,48k | 86,48% |
| 2025-06-15 | Ms. Brooke Elizabeth StoryIndependent Director | -410,00 | 18,76k | Derivative Exercise and Sale | 45,76 | 6,48k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
